A detailed history of Bellecapital International Ltd. transactions in Zoetis Inc. stock. As of the latest transaction made, Bellecapital International Ltd. holds 53,077 shares of ZTS stock, worth $8.74 Million. This represents 2.14% of its overall portfolio holdings.

Number of Shares
53,077
Previous 52,739 0.64%
Holding current value
$8.74 Million
Previous $9.14 Million 13.43%
% of portfolio
2.14%
Previous 2.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$172.58 - $196.48 $58,332 - $66,410
338 Added 0.64%
53,077 $10.4 Million
Q2 2024

Jul 19, 2024

BUY
$145.54 - $178.83 $1.81 Million - $2.23 Million
12,464 Added 30.95%
52,739 $9.14 Million
Q1 2024

May 03, 2024

BUY
$165.67 - $199.94 $219,347 - $264,720
1,324 Added 3.4%
40,275 $6.81 Million
Q4 2023

Jan 22, 2024

BUY
$151.44 - $200.09 $291,067 - $384,572
1,922 Added 5.19%
38,951 $7.69 Million
Q3 2023

Oct 17, 2023

BUY
$167.14 - $192.77 $196,222 - $226,311
1,174 Added 3.27%
37,029 $6.44 Million
Q2 2023

Jul 07, 2023

BUY
$160.94 - $186.23 $523,859 - $606,178
3,255 Added 9.98%
35,855 $6.17 Million
Q1 2023

Apr 25, 2023

BUY
$145.48 - $175.02 $397,596 - $478,329
2,733 Added 9.15%
32,600 $5.43 Million
Q4 2022

Feb 10, 2023

SELL
$131.14 - $157.47 $56,127 - $67,397
-428 Reduced 1.41%
29,867 $4.38 Million
Q3 2022

Nov 07, 2022

BUY
$148.29 - $182.55 $1.28 Million - $1.58 Million
8,650 Added 39.96%
30,295 $4.49 Million
Q2 2022

Jul 27, 2022

BUY
$155.97 - $200.09 $3.38 Million - $4.33 Million
21,645 New
21,645 $3.72 Million
Q1 2021

Apr 13, 2021

SELL
$144.0 - $169.39 $420,480 - $494,618
-2,920 Closed
0 $0
Q4 2020

Jan 14, 2021

BUY
$157.07 - $174.35 $15,235 - $16,911
97 Added 3.44%
2,920 $483,000
Q3 2020

Oct 16, 2020

BUY
$137.1 - $165.37 $387,033 - $466,839
2,823 New
2,823 $467,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Bellecapital International Ltd. Portfolio

Follow Bellecapital International Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Bellecapital International Ltd. with notifications on news.